What's new? Log in Free sign up

Enveric Biosciences (ENVB) News and press releases

Company Profile

News

From Benzinga Pro

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More

Cannabis, Earnings, News, Penny Stocks, Psychedelics, Guidance, Rumors, Financing, Offerings, Contracts, Legal, Management, Global, Markets

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program

Cannabis, News, Penny Stocks, Psychedelics, Management, Global, Markets

Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics program for anxiety disorders, EVM201, towards the clinical stage.

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More

Cannabis, News, Penny Stocks, Psychedelics, Rumors, Contracts, Small Cap, FDA, Legal, Management, Global, Markets, ETFs

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme

Cannabis, News, Penny Stocks, Psychedelics, Markets

Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a bioproduction platform for the isolation and pharmacological screening of novel molecules belonging to the indolethylamine family.

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More

Cannabis, News, Penny Stocks, Psychedelics, Events, Markets

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

'Oklahoma House Approves Psilocybin Bill Protecting Patients From Prosecution And Promoting Research' - Marijuana Moment

https://www.marijuanamoment.net/oklahoma-house-approves-psilocybin-bill-protecting-patients-from-prosecution-and-promoting-research/ The Oklahoma House of Representatives has approved a bill to promote research into the

Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person

Cannabis, News, Psychedelics, Events, Markets

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established Cannabis Capital Confere

'Hawaii Senate Approves Marijuana Legalization And Psychedelic Research Bills' - Marijuana Moment

https://www.marijuanamoment.net/hawaii-senate-approves-marijuana-legalization-and-psychedelic-research-bills/

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets

Cannabis, Earnings, News, Penny Stocks, Psychedelics, Small Cap, Events, Markets

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

'Fourth Michigan City Passes Measure To Decriminalize Psychedelics' - Marijuana Moment

https://www.marijuanamoment.net/fourth-michigan-city-passes-measure-to-decriminalize-psychedelics/ Local leaders in the city of Ferndale, Michigan, passed a resolution this week that advocates say decriminalizes

'Hawaii Senators Approve Bill To Promote Research Into Psilocybin And MDMA Therapy' - Marijuana Moment

Biotech, News, General

https://www.marijuanamoment.net/hawaii-senators-approve-bill-to-promote-research-into-psilocybin-and-mdma-therapy/ Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of

'Hawaii Senate Committee Approves Bill To Create Therapeutic Psilocybin Working Group' -Marijuana Moment Report

News, Politics, General

https://www.marijuanamoment.net/hawaii-senate-committee-approves-bill-to-create-therapeutic-psilocybin-working-group/

'Psychedelics Bills Filed In Four More States As 2023 Reform Efforts Heat Up' -Marijuana Moment Report

Cannabis, Psychedelics, Markets

https://www.marijuanamoment.net/psychedelics-bills-filed-in-four-more-states-as-2023-reform-efforts-heat-up/

'Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push' - Marijuana Moment

https://www.marijuanamoment.net/mexican-senator-to-file-psychedelics-legalization-bill-with-u-s-congressman-backing-international-reform-push/ A Mexican senator announced on Wednesday that she will be introducing a bill

'New York Governor Signs Bill To Mandate State Legalization Of Schedule I Drugs Like Psilocybin And MDMA If Federal Law Changes' - Marijuana Moment

Biotech, News, General

https://www.marijuanamoment.net/new-york-governor-signs-bill-to-mandate-state-legalization-of-schedule-i-drugs-like-psilocybin-and-mdma-if-federal-law-changes/ The governor of New York recently signed legislation

Enveric Biosciences Subsidiary Jay Pharma Receives Decision To Grant European Patent Titled 'COMPOSITIONS COMPRISING CANNABIDIOL AND SECOND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER'

https://register.epo.org/application?number=EP16801851

'Lawmakers Are Already Pursuing Psychedelics Legislation In Nearly A Dozen States For 2023: From Connecticut to California, bipartisan lawmakers are signaling strong interest in reforming laws around natural plants and fungi.' -Marijuana Moment

Cannabis, News, Markets

https://www.marijuanamoment.net/lawmakers-are-already-pursuing-psychedelics-legislation-in-nearly-a-dozen-states-for-2023/

'GOP Missouri Lawmaker Revises Therapeutic Psilocybin Legalization Bill For 2023 Session' - Marijuana Moment

https://www.marijuanamoment.net/gop-missouri-lawmaker-revises-therapeutic-psilocybin-legalization-bill-for-2023-session/ A Republican Missouri lawmaker says he plans to file a revised psychedelics bill to provide

These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

Cannabis, News, Penny Stocks, Psychedelics, Small Cap, FDA, Legal, Markets

What a year for psychedelics!

Press releases

From Benzinga Pro

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023 Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company

Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications

First-in-human clinical trial investigating Enveric's lead product candidate, EB-373 targeting anxiety disorder expected to initiate in the fourth quarter of 2023 Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the

Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery

Research details the bioproduction of novel indolethylamine-type drug candidates with potential use in psychiatric medicine Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company

Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

30+ year pharmaceutical industry veteran joins Enveric's executive team to lead company's financial and capital markets activities. Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology

Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Accomplished pharmaceutical industry leader brings to Enveric extensive experience in clinical operations, asset strategy and product development Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a

Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference

CEO Joseph Tucker, Ph.D., to deliver company presentation and participate in panel discussion Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of

Enveric Biosciences to Present at the BIO CEO & Investor Conference

Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.